Blue Granite Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,262
Closed -$1.5M 145
2017
Q3
$1.5M Sell
10,262
-9,738
-49% -$1.33M 1.03% 43
2017
Q2
$2.6M Sell
20,000
-1,000
-5% -$123K 1.68% 29
2017
Q1
$2.61M Hold
21,000
1.71% 28
2016
Q4
$2.43M Buy
+21,000
New +$2.34M 1.73% 25

Other funds holding CELG

Blue Granite Capital's CELG Position: Q4 2017 in Review

Blue Granite Capital sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 10,262 shares — an estimated $1.5M sold.

Blue Granite Capital first reported a position in CELG in Q4 2016 and held it in 4 quarters. The position peaked at $2.61M in Q1 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Blue Granite Capital reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Blue Granite Capital sold 10,262 Celgene Corp shares in Q4 2017, an estimated $1.5M.
  • Blue Granite Capital first reported a position in Celgene Corp in Q4 2016 and held it in 4 quarters.
  • Blue Granite Capital's Celgene Corp position peaked at $2.61M in Q1 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.